Skip to main content

Table 2 Clinical characteristics of patients with clinical recurrence

From: Prognostic parameters for recurrence of papillary thyroid microcarcinoma

Patient No.

1

2

3

4

5

6

7

Age/Sex

46/M

32/M

43/M

38/F

60/F

44/F

63/F

Initial Surgical extent

TT, MRND

TT, CND

TT, MRND

TT, MRND

TT, MRND

TT, CND

TT, MRND

I-131 Remnant ablation

done

Done

done

done

Done

done

done

Just before recurrence

       

   sTg (ng/mL)

58.6

34.4

17.3

13.8

33

21.5

20.7

   TgAb

negative

Negative

negative

positive

negative

negative

negative

Disease free survival (months)

9

11

13

24

31

35

43

Type of recurrence (Level of recurrent node confirmed by reoperation)c

regional (i/l II, III, IV)

regional (i/l III, SCN)

regional (i/l II, III, IV)

regional (i/l II, III, IV, SCN, VII)

regional (thyroid bed)

regional (i/l IV; c/l III, IV)

regional (i/l II, III, IV)

Additional treatment

surgery, 131I

surgery, 131I

surgery, 131I, EBRT

surgery

surgery, 131I, EBRT

surgery, 131I

surgery, 131I

Follow-up

       

   sTg (ng/mL)

UD

12.6

1.1

8.7

944a

12.4

40.0b

   TgAb

negative

negative

negative

positive

negative

negative

negative

Patient No.

8

9

10

11

12

13

14

Age/Sex

42/F

50/F

40/F

43/F

32/F

40 M

33/M

Initial Surgical extent

TT, MRND

STT

LOB

LOB

LOB, CND

LOB, CND

LOB, CND

I-131 Remnant ablation

done

not done

not done

not done

not done

not done

not done

Just before recurrence

       

   sTg (ng/mL)

1.1

N/A

N/A

N/A

N/A

N/A

N/A

   TgAb

neg

N/A

N/A

N/A

N/A

N/A

N/A

Disease free survival (months)

99

8

10

15

44

53

63

Type of recurrence (Level of recurrent node confirmed by reoperation)c

regional (i/l II, III)

regional (i/l III, IV)

local (c/l lobe)

local (c/l lobe)

local (c/l lobe)

local (c/l lobe)

local (c/l lobe)

Additional treatment

surgery, 131I

surgery, 131I

follow-up loss

surgery, 131I

surgery, 131I

surgery, 131I

surgery, 131I

Follow-up

       

   sTg (ng/mL)

UD

UD

 

UD

UD

UD

UD

   TgAb

negative

positive

 

negative

negative

negative

negative

  1. a Chest CT suggested multiple lung metastases. This patient underwent additional surgery and radioiodine treatment, but no iodide uptake was noted during a post-treatment whole body scan. This patient, however, showed progressive, multiple, unresectable, cervical, mediastinal, and lung metastases, and EBRT was performed to control locally advanced disease.
  2. b Chest CT and FDG-PET suggested multiple lung metastases. This patient underwent additional surgery and radioiodine treatment, but no iodide uptake was noted during a post-treatment whole body scan. This was followed by thyroxine suppression, with no definitive evidence of disease progression observed on serial chest CT scans.
  3. sTg, stimulated thyroglobulin; TT, total thyroidectomy; STT, subtotal thyroidectomy; LOB, lobectomy; CND, central neck node dissection; MRND, modified radical neck dissection; UD, undetectable; N/A, not applicable; i/l, ipsilateral; c/l, contralateral; EBRT, external beam radiation treatment.